- Home
- FFIN vs WGS Comparison
FFIN vs WGS Comparison
Compare FFIN & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FFIN | WGS |
|---|---|---|
| Founded | 1890 | 2017 |
| Country | United States | United States |
| Employees | 1500 | N/A |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FFIN | WGS |
|---|---|---|
| Price | $32.05 | $136.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $37.50 | ★ $138.13 |
| AVG Volume (30 Days) | ★ 905.9K | 382.4K |
| Earning Date | 01-22-2026 | 02-17-2026 |
| Dividend Yield | ★ 2.45% | N/A |
| EPS Growth | ★ 16.54 | N/A |
| EPS | ★ 1.69 | 0.07 |
| Revenue | ★ $581,881,000.00 | $402,190,000.00 |
| Revenue This Year | $21.45 | $41.17 |
| Revenue Next Year | $6.75 | $23.53 |
| P/E Ratio | ★ $18.35 | $1,856.84 |
| Revenue Growth | 14.03 | ★ 50.50 |
| 52 Week Low | $29.44 | $55.17 |
| 52 Week High | $39.12 | $170.87 |
Technical Indicators
Market Signals| Indicator | FFIN | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 60.26 | 46.39 |
| Support Level | $29.44 | $124.26 |
| Resistance Level | $31.00 | $138.73 |
| Average True Range (ATR) | 0.72 | 5.87 |
| MACD | 0.11 | -0.15 |
| Stochastic Oscillator | 89.29 | 63.97 |
Price Performance
Historical ComparisonAbout FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto. It derives maximum revenue from Construction and Development Segment.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.